| Literature DB >> 35450122 |
Yong-Xia Mei1,2,3, Zhen-Xiang Zhang1, Hui Wu4,5,6, Jian Hou2, Xiao-Tian Liu2, Sheng-Xiang Sang2, Zhen-Xing Mao2, Wei-Hong Zhang1, Dong-Bin Yang3, Chong-Jian Wang2.
Abstract
Background: Stroke is a major health threat and the leading cause of mortality and disability in China. The aims of this study were to identify the possible influencing factors of health-related quality of life (HRQoL) and its domain-specific contents in stroke patients in rural areas in China.Entities:
Keywords: EQ-5D-5L; HRQoL; influencing factors; rural; stroke
Mesh:
Year: 2022 PMID: 35450122 PMCID: PMC9016152 DOI: 10.3389/fpubh.2022.810185
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Definitions and coding schema for patients with stroke' sociodemographic variables.
|
|
|
|---|---|
| Age | <55 = 1; 55~= 2; ≥65 = 3 |
| Sex | Male = 1; Female = 2 |
| Marital status | Categorized as married/cohabiting and widowed/unmarried/divorced/separated |
| Spouse | Defined as whether a patient with stroke was accompanied by a spouse and categorized as yes or no |
| Educational level | Categorized as illiterate, primary school, junior high school, or above |
| Per capita monthly actual income | Categorized as < $72 (US dollars), $72 ~ $143, and >$143 |
| Smoking status | Defined as at least one cigarette per day for the previous 6 months |
| Drinking status | Defined as alcohol consumption 12 times per year |
| Duration of illness (years) | Defined as how long since the first stroke and categorized as <1, ≥1 to <3, ≥3 to <5, or ≥5 years |
Distribution of stroke patients within different subgroups over reporting problems (slight to extreme problems) of the EQ-5D dimension, mean (SD) EQ−5D utility index, and VAS score (n = 1,709).
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||
|
| ||||||||
| <55 | 237 (13.90) | 46 (19.40) | 21 (8.90) | 29 (12.20) | 67 (28.30) | 24 (10.10) | 0.92 (0.16) | 69.58 (17.84) |
| 55 ~ 65 | 580 (33.90) | 155 (26.70) | 54 (9.30) | 88 (15.20) | 191 (32.90) | 58 (10.00) | 0.90 (0.18) | 68.97 (17.58) |
| 65~ | 892 (52.20) | 319 (35.80) | 147 (16.50) | 215 (24.10) | 343 (38.50) | 120 (13.50) | 0.86 (0.23) | 67.70 (16.98) |
|
| <0.001 | <0.001 | <0.001 | 0.005 | 0.092 | <0.001 | 0.203 | |
|
| ||||||||
| Female | 905 (53.00) | 266 (29.40) | 116 (12.80) | 175 (19.30) | 356 (39.30) | 133 (14.70) | 0.87 (0.21) | 68.17 (17.76) |
|
| 0.324 | 0.822 | 0.921 | <0.001 | <0.001 | 0.005 | 0.583 | |
|
| ||||||||
| Illiterate | 425 (24.90) | 149 (35.10) | 66 (15.50) | 97 (22.80) | 175 (41.20) | 60 (14.10) | 0.86 (0.22) | 67.72 (18.45) |
| Primary school | 596 (34.90) | 194 (32.60) | 82 (13.80) | 129 (21.60) | 232 (38.90) | 77 (12.90) | 0.87 (0.22) | 67.18 (17.15) |
| Other | 688 (40.30) | 177 (25.70) | 74 (10.80) | 106 (15.40) | 194 (28.20) | 65 (9.40) | 0.91 (0.18) | 69.85 (16.61) |
|
| 0.002 | 0.056 | 0.002 | 0.100 | 0.038 | <0.001 | 0.014 | |
|
| ||||||||
| Yes | 1,458 (85.30) | 436 (29.90) | 191 (13.10) | 279 (19.10) | 508 (34.80) | 168 (11.50) | 0.88 (0.21) | 68.43 (17.17) |
|
| 0.257 | 0.744 | 0.464 | 0.498 | 0.359 | 0.812 | 0.688 | |
|
| ||||||||
| <72 | 801 (46.90) | 282 (35.20) | 126 (15.70) | 187 (23.30) | 316 (39.50) | 112 (14.00) | 0.86 (0.22) | 65.79 (17.63) |
| 72 ~ 143 | 500 (29.30) | 150 (30.00) | 61 (12.20) | 96 (19.20) | 158 (31.60) | 53 (10.60) | 0.90 (0.19) | 69.63 (16.61) |
| 143~ | 408 (23.90) | 88 (21.60) | 35 (8.60) | 49 (12.00) | 127 (31.10) | 37 (9.10) | 0.92 (0.18) | 71.97 (16.76) |
|
| <0.001 | 0.012 | <0.001 | 0.013 | 0.020 | <0.001 | <0.001 | |
|
| ||||||||
| Never | 1,140 (66.70) | 346 (30.40) | 157 (13.80) | 233 (20.40) | 433 (38.00) | 166 (14.60) | 0.87 (0.21) | 67.92 (17.54) |
| Former | 276 (16.10) | 91 (33.00) | 36 (13.00) | 51 (18.50) | 82 (29.70) | 15 (5.40) | 0.91 (0.18) | 70.00 (16.81) |
| Current | 293 (17.10) | 83 (28.30) | 29 (9.90) | 48 (16.40) | 86 (29.40) | 21 (7.20) | 0.89 (0.18) | 68.63 (16.83) |
|
| 0.483 | 0.213 | 0.267 | 0.003 | <0.001 | 0.007 | 0.179 | |
|
| ||||||||
| Never | 1,287 (75.30) | 384 (29.80) | 172 (13.40) | 253 (19.70) | 464 (36.10) | 174 (13.50) | 0.88 (0.21) | 67.96 (17.19) |
| Former | 205 (12.00) | 87 (40.10) | 37 (17.10) | 55 (25.30) | 76 (35.00) | 14 (6.50) | 0.92 (0.17) | 73.70 (15.57) |
| Current | 217 (12.70) | 49 (23.90) | 13 (6.30) | 24 (11.70) | 61 (29.80) | 14 (6.80) | 0.88 (0.18) | 66.26 (18.82) |
|
| 0.001 | 0.003 | 0.002 | 0.215 | 0.001 | 0.024 | <0.001 | |
|
| ||||||||
| Yes | 166 (9.70) | 40 (24.10) | 13 (7.80) | 21 (12.70) | 56 (33.70) | 18 (10.80) | 0.91 (0.16) | 70.93 (16.18) |
|
| 0.062 | 0.037 | 0.020 | 0.684 | 0.682 | 0.079 | 0.046 | |
|
| ||||||||
| Yes | 722 (42.20) | 184 (25.50) | 86 (11.90) | 119 (16.50) | 236 (32.70) | 65 (9.00) | 0.90 (0.19) | 69.59 (16.90) |
|
| <0.001 | 0.257 | 0.009 | 0.066 | 0.002 | 0.007 | 0.014 | |
|
| ||||||||
| Mild | 748 (43.80) | 306 (40.90) | 154 (20.60) | 213 (28.50) | 285 (38.10) | 97 (13.00) | 0.84 (0.25) | 67.32 (17.68) |
| Moderate | 536 (31.40) | 131 (24.40) | 51 (9.50) | 80 (14.90) | 180 (33.60) | 63 (11.80) | 0.91 (0.16) | 68.39 (18.11) |
| Intense | 425 (24.90) | 83 (19.50) | 17 (4.00) | 39 (9.20) | 136 (32.00) | 42 (9.90) | 0.93 (0.11) | 70.26 (15.41) |
|
| <0.001 | <0.001 | <0.001 | 0.071 | 0.290 | <0.001 | 0.201 | |
| <18.5 | 37 (2.19) | 13 (35.10) | 4 (10.80) | 6 (16.20) | 14 (37.80) | 11 (29.70) | 0.85 (0.26) | 62.14 (21.19) |
| 18.5 ≤ BMI <24.0 | 587 (34.67) | 164 (27.90) | 72 (12.30) | 113 (19.30) | 210 (35.80) | 63 (10.70) | 0.89 (0.19) | 67.98 (16.60) |
| 24.0 ≤ BMI <28.0 | 739 (43.65) | 212 (28.70) | 84 (11.40) | 127 (17.20) | 244 (33.00) | 86 (11.60) | 0.90 (0.19) | 69.02 (17.30) |
| ≥28.0 | 330 (19.49) | 118 (35.80) | 51 (15.50) | 74 (22.40) | 126 (38.20) | 38 (11.50) | 0.87 (0.22) | 68.86 (17.86) |
|
| 0.058 | 0.304 | 0.230 | 0.388 | 0.007 | 0.121 | 0.852 | |
| Yes | 917 (54.00) | 293 (32.00) | 119 (13.00) | 182 (19.80) | 322 (35.10) | 114 (12.40) | 0.88 (0.20) | 68.79 (17.20) |
|
| 0.073 | 0.622 | 0.391 | 0.995 | 0.328 | 0.160 | 0.389 | |
| abnormal | 1,268 (74.72) | 124 (28.90) | 49 (12.20) | 74 (18.50) | 141 (35.20) | 41 (10.20) | 0.88 (0.20) | 68.64 (17.10) |
|
| 0.021 | <0.001 | 0.705 | 0.970 | 0.283 | 0.385 | 0.451 | |
|
| ||||||||
| <1 | 209 (12.20) | 54 (25.80) | 25 (12.00) | 32 (15.30) | 76 (36.40) | 25 (12.00) | 0.90 (0.17) | 70.91 (16.38) |
| ≥1– <3 | 486 (28.40) | 123 (25.30) | 52 (10.70) | 76 (15.60) | 161 (33.10) | 52 (10.70) | 0.90 (0.19) | 69.09 (17.35) |
| ≥3– <5 | 347 (20.30) | 97 (28.00) | 36 (10.40) | 63 (18.20) | 121 (34.90) | 38 (11.00) | 0.90 (0.19) | 68.39 (17.97) |
| ≥5 | 663 (38.8) | 245 (37.00) | 109 (16.40) | 161 (24.30) | 241 (36.30) | 86 (13.00) | 0.86 (0.23) | 67.12 (17.18) |
|
| <0.001 | 0.009 | 0.001 | 0.697 | 0.640 | 0.200 | 0.320 | |
|
| ||||||||
| Yes | 727 (42.50) | 258 (35.50) | 108 (14.90) | 163 (22.40) | 248 (34.10) | 84 (11.60) | 0.87 (0.21) | 66.93 (16.80) |
|
| <0.001 | 0.048 | 0.007 | 0.432 | 0.770 | 0.049 | 0.003 | |
|
| ||||||||
| Yes | 236 (13.80) | 95 (40.30) | 39 (16.50) | 60 (25.40) | 85 (36.00) | 32 (13.60) | 0.84 (0.27) | 66.58 (16.97) |
|
| <0.001 | 0.082 | 0.012 | 0.768 | 0.373 | <0.001 | 0.083 | |
| GAD-2 ≥ 3 | 154 (9.00) | 71 (46.10) | 40 (26.00) | 54 (35.10) | 108 (70.10) | 76 (49.40) | 0.71 (0.32) | 60.39 (19.09) |
|
| <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
| PHQ-2 | 183 (10.70) | 96 (52.50) | 51 (27.90) | 76 (41.50) | 121 (66.10) | 87 (47.50) | 0.69 (0.33) | 59.75 (20.07) |
|
| <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
| PSQI > 5 | 513 (30.02) | 320 (26.40) | 120 (9.90) | 188 (15.50) | 353 (29.10) | 100 (8.30) | 63.78 (17.31) | 0.82 (0.26) |
|
| <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
GAD-2, Generalized anxiety disorder scale-2; PHQ-2, Patient health questionnaire-2; PSQI, the Pittsburgh sleep quality index;
P < 0.05;
P < 0.001.
Figure 1(A) Distribution of EQ-5D-5l scores (n = 1,709); (B) distribution of EQ-VAS scores (n = 1,709).
Figure 2The risk factors for low scores in each EQ-5D dimension [Mobility, Self-care (SC), Usual activities (UA), Pain/discomfort and Anxiety/depression (AD)] among patients with stroke (n = 1,709) identified by multiple logistic regression analysis. The black dots with the corresponding error bars represented the estimated effect and 95% confidence intervals of the change in each of variables. A two-sided P-value 0.05 was considered statistically significant.
Figure 3Factors associated with EQ-5D-5L utility index and Visual Analogue Scale scores in patients with stroke were analyzed by Tobit regression and Generalized linear model, respectively (n = 1,709). The estimated effect and 95% confidence intervals were represented by black squares with the corresponding error bars. A two-sided P-value 0.05 was considered statistically significant.